INNODIA BOARD

INNODIA has a board that provides strategic decision-making, guidance oversight and accountability. The board is made of one representative from each founding members, prime members, and funders; one representative from full members elected by the general assembly; and one associate from the community of people and families living with type 1 diabetes (INPACT) for a maximum of 15 board of directors.

Image
Chantal Mathieu

Chantal Mathieu - President

Katholieke Universiteit Leuven, Belgium
Head of Diabetes Lab at KULeuven and Head of Endocrinology Department at UZ Leuven
Image
Thomas Danne

Thomas Danne - (vice-president)

Hannoverische Kinderheilanstalt Germany
Director of the Department of General Pediatrics and Endocrinology/Diabetology and Clinical Research
Image
Francesco Dotta

Francesco Dotta

Università di Siena, Italy
Head of the Department of Medicine, Surgery and Neuroscience, Professor of Endocrinology and Director of Diabetes
Image
Thomas Pieber

Thomas Pieber

Medizinischen Universität Graz, Austria
Professor of Medicine, Head of the Division of Endocrinology and Metabolism and Chairman of the Dpt. of Internal Medicine
Image
Tim Tree

Timothy Tree

King’s College London, UK
Professor of Immune Regulation and Immuno-therapy
Image
Roberto Mallone iVZW website

Roberto Mallone

Inserm Cochin Institute, France
Professor of Immunology, Diabetologist and Research Team Leader
Image
Gina Agiostratidou

Gina Agiostratidou

Helmsley Charitable Trust
Program Director Type 1 Diabetes program
Image
Jeannette Soderberg 3

Jeannette Soderberg

Juvenile Diabetes Research Foundation
Director European Research
Image
Martin Ridderstrale 2

Martin Ridderstråle

Novo Nordisk Foundation
Senior Vice President, Medical Science
Image
Francesca Ulivi INPACT

Francesca Ulivi

INPACT Representative

INNODIA MANAGEMENT TEAM

INNODIA is managed by a team of professionals who steer the organization, implement the organization’s strategy and translate into actions all major decisions taken by the governing board and the general assembly.

Image
Manuela 2

Manuela Battaglia

Managing Director
Image
Lut Overbergh OPERATIONS COORDINATOR

Lutgart Overbergh

Operations Coordinator
Image
beeld voor test pagina

Veerle Vanhuyse

Communication Manager
Image
Vanessa Smets

Vanessa Smets

Office Manager
Image
Nicole Koller

Nicole Koller

Clinical Trial Site Network Coordinator

Open positions in the management team 

CLINICAL TRIAL SITE NETWORK MANAGER

Does this job not apply to you and yet, you're interested in working with INNODIA? Send us an open application: info@innodia.org


INNODIA GENERAL ASSEMBLY

The INNODIA general assembly is made of representatives from all members and it has the power to admit new members and approve the organisational strategies and policies. In addition to all board members, one representative from every full member has the voting rights in the general assembly (list of INNODIA full members below).


INNODIA PEOPLE and FAMILIES LIVING WITH TYPE 1 DIABETES (INPACT)

INNODIA originates from and is pointed towards people and families living with type 1 diabetes. We are based on a community of experts capable of influencing the drug-development process from research to clinical development.

INPACT


Image
Francesca
"Type 1 diabetes is one of the most complex and heterogeneous diseases
and no one can solve the “Cluedo” of its pathogenesis by themselves.
Only International communities of clinicians, scientists and people with diabetes, working together, can accelerate the path to a cure.
This is why INNODIA is so crucial"!  
Francesca Ulivi
INPACT

                                                               

Image
interested in working with us

Job opportunities

Clinical Trial Site Network Manager

Find out more 

Does this job not apply to you and yet, you're interested in working with INNODIA? Send us an open application: info@innodia.org